BOSTON, MA (PRWEB) DECEMBER 09, 2016
Aditya Humad, Acting CFO of AxioMed and Managing Partner of KICVentures, is pleased to announce that in addition to Australia, Europe, and the United States, Axiomed is now gaining interest from Silicon Valley. “It was satisfying to complete the due diligence required to assure interest in this technology.”
Mr. Humad went on to say that, “We expect interest to continue to rise as AxioMed completes its cleanroom assembly to begin manufacturing the cervical and lumbar viscoelastic disc for international distribution to meet an anticipated high demand.” AxioMed completed its IDE in August 2016 and is preparing a submission to the FDA for the clearance of its viscoelastic lumbar disc.
Dr. Kingsley R. Chin, Acting CEO of AxioMed and Managing Partner at KICVentures has been spending more time in Silicon Valley and is quoted as saying, “I feel I share a lot in common with the entrepreneurs in Silicon Valley. I have a tremendous respect for their accomplishments in a broad range of technologies and I feel they have a lot of respect for my knowledge, track record, and experience in health technology. Experts in Silicon Valley have expressed the importance of the potential disruption the seems eminent within healthcare. Time and time again, I get the feedback that AxioMed’s viscoelastic technology seems intuitive over all other existing technologies for spine surgery. They also feel that the clinical and biomechanical results so far are very convincing. I expect interest to build as we demonstrate continued progress.”
Founded in 2001, AxioMed (http://www.axiomed.com/) began its journey of exhaustively proving the Freedom® Disc through clinical studies in the USA and Europe, research, development and testing. In 2014, KICVentures recognized the disc’s enormous potential and acquired the company into their healthcare portfolio. AxioMed owns an exclusive viscoelastic material license on its proprietary Freedom Disc technology.